GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Telmisartan - MICARDIS / conventional tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordAll source differencesRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

GlobalRPh RX List - Micardis

Product / population
Single-ingredient oral telmisartan; not fixed combinations.
Renal method
No numeric renal threshold in the selected initial-dose instruction
Source revision
Revision not established in selected sections
Retrieved
2026-09-10
Local review status
Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Before use: Telmisartan - MICARDIS / conventional tablets

No initial adjustment does not remove dialysis hypotension or potassium/renal monitoring.

What to reconcile: Confirm the exact product, indication, renal measure and full source before prescribing.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Rxlist

GlobalRPh RX List - Micardis

Open original reference

GlobalRPh-hosted RX List · Single-ingredient oral telmisartan; not fixed combinations.

Renal method: No numeric renal threshold in the selected initial-dose instruction
Source date: Revision not established in selected sections
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Before using this finding

Confirm the exact product, indication, renal measure and full source before prescribing.

Dialysis evidence: Qualified no-adjustment instruction; review dialysis evidence limits

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

Dialysis patients can develop orthostatic hypotension. Follow potassium, renal function and volume status; avoid routine dual renin-angiotensin-system blockade.

Stop promptly when pregnancy is detected. A no-adjustment instruction does not exclude acute kidney injury or hyperkalemia.

Telmisartan - initial renal adjustment
Renal populationSource-specific dose / instruction
Renal impairment including hemodialysisNo initial renal dose adjustment; closely monitor blood pressure in dialysis
Read the retained text before reformatting

Telmisartan - initial renal adjustment

Renal populationSource-specific dose / instruction
Renal impairment including hemodialysisNo initial renal dose adjustment; closely monitor blood pressure in dialysis

Dialysis patients can develop orthostatic hypotension. Follow potassium, renal function and volume status; avoid routine dual renin-angiotensin-system blockade.

Stop promptly when pregnancy is detected. A no-adjustment instruction does not exclude acute kidney injury or hyperkalemia.

RDM63-rxlist-telmisartan-c1903e858f-C1 · Source locator: Dosage 2.1; warnings 5.1-5.6

Source-specific limits

Dialysis patients can develop orthostatic hypotension. Follow potassium, renal function and volume status; avoid routine dual renin-angiotensin-system blockade.

Stop promptly when pregnancy is detected. A no-adjustment instruction does not exclude acute kidney injury or hyperkalemia.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/micardis-drug/
Retrieved
2026-09-10
Renal-function method
No numeric renal threshold in the selected initial-dose instruction
Source date/version
Revision not established in selected sections
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
017e9f7cc022e16f8545efe53656fdf1302fca17a763f2549ded37b93d392b06

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=telmisartan&s1=RDM63-rxlist-telmisartan-c1903e858f&h1=ddc188074de7254eb2a739317884adc3965fd086b142d6980c4aa17e36f0450e